These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29140957)

  • 41. Renin-angiotensin system overactivation in perivascular adipose tissue contributes to vascular dysfunction in heart failure.
    Fontes MT; Paula SM; Lino CA; Senger N; Couto GK; Barreto-Chaves MLM; Mill JG; Rossoni LV
    Clin Sci (Lond); 2020 Dec; 134(23):3195-3211. PubMed ID: 33215657
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of telomerase reverse transcriptase in the mitochondrial protective functions of Angiotensin-(1-7) in diabetic CD34
    Jahan J; Joshi S; Oca IM; Toelle A; Lopez-Yang C; Chacon CV; Beyer AM; Garcia CA; Jarajapu YP
    Biochem Pharmacol; 2024 Apr; 222():116109. PubMed ID: 38458330
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of Angiotensin-converting Enzyme 2 Protects Against Lipopolysaccharide-induced Glial Activation by Modulating Angiotensin-converting Enzyme 2/Angiotensin (1-7)/Mas Receptor Axis.
    Tiwari P; Tiwari V; Gupta S; Shukla S; Hanif K
    Mol Neurobiol; 2023 Jan; 60(1):203-227. PubMed ID: 36251234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Upregulation of Angiotensin (1-7)-Mediated Signaling Preserves Endothelial Function Through Reducing Oxidative Stress in Diabetes.
    Zhang Y; Liu J; Luo JY; Tian XY; Cheang WS; Xu J; Lau CW; Wang L; Wong WT; Wong CM; Lan HY; Yao X; Raizada MK; Huang Y
    Antioxid Redox Signal; 2015 Oct; 23(11):880-92. PubMed ID: 25867182
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recombinant human angiotensin-converting enzyme 2 as a new renin-angiotensin system peptidase for heart failure therapy.
    Oudit GY; Penninger JM
    Curr Heart Fail Rep; 2011 Sep; 8(3):176-83. PubMed ID: 21611889
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The angiotensin-converting enzyme 2/angiotensin (1-7)/Mas axis protects against lung fibroblast migration and lung fibrosis by inhibiting the NOX4-derived ROS-mediated RhoA/Rho kinase pathway.
    Meng Y; Li T; Zhou GS; Chen Y; Yu CH; Pang MX; Li W; Li Y; Zhang WY; Li X
    Antioxid Redox Signal; 2015 Jan; 22(3):241-58. PubMed ID: 25089563
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Roles of Angiotensin Peptides and Recombinant Human ACE2 in Heart Failure.
    Basu R; Poglitsch M; Yogasundaram H; Thomas J; Rowe BH; Oudit GY
    J Am Coll Cardiol; 2017 Feb; 69(7):805-819. PubMed ID: 28209222
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Interplay between the Renin Angiotensin System and Pacing Postconditioning Induced Cardiac Protection.
    Babiker F; Al-Jarallah A; Joseph S
    PLoS One; 2016; 11(11):e0165777. PubMed ID: 27814397
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Angiotensin-(1-7) suppresses the number and function of the circulating fibrocytes by upregulating endothelial nitric oxide synthase expression.
    Wang K; Hu X; Du C; Tu S; Zhang F; Xie X
    Mol Cell Biochem; 2012 Jun; 365(1-2):19-27. PubMed ID: 22456996
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of renin-angiotensin system in liver diseases: an outline on the potential therapeutic points of intervention.
    Ahmadian E; Pennefather PS; Eftekhari A; Heidari R; Eghbal MA
    Expert Rev Gastroenterol Hepatol; 2016 Nov; 10(11):1279-1288. PubMed ID: 27352778
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases.
    Parajuli N; Ramprasath T; Patel VB; Wang W; Putko B; Mori J; Oudit GY
    Can J Physiol Pharmacol; 2014 Jul; 92(7):558-65. PubMed ID: 24861775
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased number of circulating progenitor cells after implantation of ventricular assist devices.
    Manginas A; Tsiavou A; Sfyrakis P; Giamouzis G; Tsourelis L; Leontiadis E; Degiannis D; Cokkinos DV; Alivizatos PA
    J Heart Lung Transplant; 2009 Jul; 28(7):710-7. PubMed ID: 19560700
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat.
    Lubel JS; Herath CB; Tchongue J; Grace J; Jia Z; Spencer K; Casley D; Crowley P; Sievert W; Burrell LM; Angus PW
    Clin Sci (Lond); 2009 Sep; 117(11):375-86. PubMed ID: 19371232
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circulating proangiogenic progenitor cells independently predict functional capacity in heart failure patients.
    Alba AC; Lalonde SD; Rao V; Walter S; Guyatt GH; Ross HJ
    Can J Cardiol; 2013 Jun; 29(6):664-71. PubMed ID: 23142345
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice.
    Patel VB; Bodiga S; Fan D; Das SK; Wang Z; Wang W; Basu R; Zhong J; Kassiri Z; Oudit GY
    Hypertension; 2012 Jun; 59(6):1195-203. PubMed ID: 22508831
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angiotensin-(1-7): pharmacology and new perspectives in cardiovascular treatments.
    Trask AJ; Ferrario CM
    Cardiovasc Drug Rev; 2007; 25(2):162-74. PubMed ID: 17614938
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Attenuating effect of angiotensin-(1-7) on angiotensin II-mediated NAD(P)H oxidase activation in type 2 diabetic nephropathy of KK-A(y)/Ta mice.
    Moon JY; Tanimoto M; Gohda T; Hagiwara S; Yamazaki T; Ohara I; Murakoshi M; Aoki T; Ishikawa Y; Lee SH; Jeong KH; Lee TW; Ihm CG; Lim SJ; Tomino Y
    Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1271-82. PubMed ID: 21367916
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypoxic regulation of angiotensin-converting enzyme 2 and Mas receptor in human CD34
    Joshi S; Wollenzien H; Leclerc E; Jarajapu YP
    J Cell Physiol; 2019 Nov; 234(11):20420-20431. PubMed ID: 30989646
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An oral formulation of angiotensin-(1-7) reverses corpus cavernosum damages induced by hypercholesterolemia.
    Fraga-Silva RA; Costa-Fraga FP; Savergnini SQ; De Sousa FB; Montecucco F; da Silva D; Sinisterra RD; Mach F; Stergiopulos N; da Silva RF; Santos RA
    J Sex Med; 2013 Oct; 10(10):2430-42. PubMed ID: 23890028
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antagonism of angiotensin 1-7 prevents the therapeutic effects of recombinant human ACE2.
    Patel VB; Takawale A; Ramprasath T; Das SK; Basu R; Grant MB; Hall DA; Kassiri Z; Oudit GY
    J Mol Med (Berl); 2015 Sep; 93(9):1003-13. PubMed ID: 25874965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.